Keep track of Intently (2)pentobarbital will decrease the extent or impact of suvorexant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of. Potent CYP3A4 inducers could lower suvorexant efficacy; if increased suvorexant dose essential, never exceed 20 mg/daypentobarbital will decrease the level or impact of repagli